Govt likely to extend incentive scheme IFLADP for leather, footwear industry till 2025-26
The Hindu
The government is likely to extend an incentive scheme for leather and footwear industries, IFLADP, till 2025-26 with an outlay of ₹1,700 crore, to further boost manufacturing, exports and job creatio
The government is likely to extend an incentive scheme for leather and footwear industries, IFLADP, till 2025-26 with an outlay of ₹1,700 crore, to further boost manufacturing, exports and job creation, an official said. The Commerce and Industry Ministry has submitted a proposal for implementation of the Indian Footwear Leather and Accessories Development Programme (IFLADP) with an outlay of ₹1,700 crore, to be incurred during 2021-22 to 2025-26, and the Union Cabinet may soon approve the same, the official said. The programme has six components — Sustainable Technology and Environmental Promotion (proposed outlay ₹500 crore); Integrated Development of Leather Sector (proposed outlay ₹500 crore); Establishment of Institutional Facilities (₹200 crore); Mega Leather Footwear and Accessories Cluster Development (₹300 crore); Brand Promotion of Indian Brands in Leather and Footwear Sector (₹100 crore); and Development of Design Studios (₹100 crore).
RBI Governor Shaktikanta Das admitted to hospital for monitoring, no official information available yet.
Fitch puts Adani Group bonds on watch for downgrade after U.S. bribery charges, impacting financial stability and investments.
Google is fighting to beat back another attack by the U.S. Department of Justice alleging monopolistic conduct in its ad tech.
Meta will face trial in April over the U.S. Federal Trade Commission’s allegations that the social media platform bought Instagram and WhatsApp to crush emerging competition.
HUL shareholders to receive shares in new ice cream business entity, subject to approvals, maximizing value for all.
Vedanta launches $500 million bond issue post-Adani crisis, with Citigroup, JPMorgan, Deutsche Bank declining to comment.
USFDA reports Dr Reddy's and Lupin Pharmaceuticals recalling products in the US due to manufacturing issues.
EPF inoperative accounts rise to ₹8,505.23 crore in 2023-24, EPFO to return funds to beneficiaries, awareness campaigns planned.
S&P Global Ratings revises India's economic growth forecast due to high interest rates and lower fiscal impulse.
Indraprastha Gas Ltd raises CNG prices in select cities, while MGL hikes rates in Mumbai post-elections.
Adani group stocks surge on BSE, NSE; clarifies on Kenya deals amid bribery charges, airport project cancellation.